The ototoxicity of deferoxamine mesylate.
Kanno
H
H
Department of Surgery, Southern Illinois University, School of Medicine, Springfield, USA.
Yamanobe
S
S
Rybak
L P
LP
D001301:Audiometry, Pure-Tone; D003051:Cochlea / Q000187:drug effects / Q000503:physiopathology; D003676:Deferoxamine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006314:Hearing Loss, Conductive / Q000175:diagnosis / Q000209:etiology; D006319:Hearing Loss, Sensorineural / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D013789:Thalassemia / Q000188:drug therapy; D014012:Tinnitus / Q000209:etiology
D003676:Deferoxamine